macrocyclic peptides targeting cyclinA/cdk-2 (Circle Pharma)

N/A

Report date: 2025/03/20 15:42:09

Base Information

Drug Namemacrocyclic peptides targeting cyclinA/cdk-2 (Circle Pharma)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionCyclin-dependent kinase 2 modulatorsCyclin A modulators

TargetsCyclin-dependent kinase 2Cyclin A

Therapy Area/IndicationsSmall Cell Lung CarcinomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCircle Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsNeoplasms

ATC CodeN/A